Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

141.29 -0.15 (-0.11%)
Official Closing Price Updated: 7:00 PM EDT, Aug 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
ABBVIE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AbbVie Inc. - ABBV
From Kahn Swick & Foti, LLC
Via Business Wire
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 6.01% on an annualized basis producing an average annual return of 15.88%. Currently, AbbVie has a market capitalization of... 
Via Benzinga
AbbVie Whale Trades Spotted
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
AbbVie Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 29 strange trades. 
Via Benzinga
AbbVie - Genmab Present Epcoritamab Data From Lymphoma Trial
 
Via Benzinga
Consistent Clinical Results Indicate Upside for AbbVie Stock
ABBV stock trades at a reasonable valuation and can move higher. Meanwhile, AbbVie's financials and dividend payments sweeten the deal. 
Via InvestorPlace
AbbVie Whale Trades For June 01
A whale with a lot of money to spend has taken a noticeably bullish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 10 strange trades. 
Via Benzinga
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
Via InvestorPlace
6 Best Dividend Stocks of All Time
When you're ready to say, "Tag, you're it!" and let dividend stocks take over your portfolio, you naturally want to gravitate toward A+ companies. Luckily, you don't need to look much further than... 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Why AbbVie Stock Is Trading Higher Today
AbbVie Inc (NYSE: ABBV) shares are trading higher Tuesday after the company announced it submitted a supplemental New Drug Application for atogepant to the U.S. Food and Drug Administration to support... 
Via Benzinga
Jim Cramer Says This Is A Terrific Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rapid7, Inc. (NASDAQ: RPD) doesn’t make money, so he will not go for it. 
Via Benzinga
The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
BioMedNewsBreaks – Odyssey Health Inc.’s (ODYY) Novel Drug Candidate Represents a Valuable Asset
Via Investor Brand Network
AbbVie Signs Licensing Deal With Sirona Biochem For Effective New Hydroquinone Alternative
AbbVie acquires the rights to market and commercialize Sirona’s breakthrough TFC-1067 compound AbbVie agrees to upfront, milestone, and royalty payments for patented molecules Sirona’s TFC-1067 is... 
Via Zexprwire
Topics Intellectual Property
Exposures Intellectual Property
AbbVie Whale Trades For June 14
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
5 Pharma Company Analyst Targets and most Bullish Case for each
Via AB Newswire
7 Dividend Stocks to Buy for Your Grandkids
If this roiling market is making you seasick, then it's an excellent time to batten down the hatches with these reliable dividend stocks. 
Via InvestorPlace
7 Great ETFs to Buy Now for Momentum in Q2
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments. 
Via InvestorPlace
3 Dividend Stocks to Buy Now for 20 Years of Income Growth
Investors looking for passive income from holding stocks should consider these dividend stocks that offer strong payouts. 
Via InvestorPlace
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 5.42% on an annualized basis producing an average annual return of 16.4%. Currently, AbbVie has a market capitalization of... 
Via Benzinga
Johnson & Johnson-AbbVie Partnered Lymphoma Drug Slows Disease Progression, Data Shows
 
Via Benzinga
Final Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Notifies AbbVie, Inc. (ABBV) Investors of Class Action and Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ABBV FINAL DEADLINE MONDAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action - ABBV
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ABBVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AbbVie, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
NYSE:ABBV Investor Alert: Deadline on JUNE 6, 2022 in Lawsuit Against AbbVie Inc.
San Diego, CA -- (SBWIRE) -- 06/02/2022 -- The Shareholders Foundation announced that a deadline is coming up on JUNE 6, 2022, in the lawsuit filed for certain investors of AbbVie Inc. (NYSE:ABBV) 
Via SBWire
It’s a Market of Stocks Not a Stock Market
Stocks are as individual as people. What really matters, in the long run, is how well the business is operated, which will always be reflected in the fundamentals. 
Via Talk Markets
7 Safe Dividend Stocks With High Yields to Buy Now
Investors are seeking dividend stocks. Here are seven safe dividend stocks that offer a high yield to maximize their total return. 
Via InvestorPlace
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... 
Via Benzinga
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages AbbVie Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 6 Deadline in Securities Class Action - ABBV
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.